Reasons for Escalating Pacemaker Implants

David H. Birnie(University of Ottawa), Anthony Tang(Western University), Michael H. Gollob(University of Toronto), Darryl R. Davis(University of Ottawa), Kathryn Williams(Boston Children's Hospital), Ann Guo(University of Ottawa), Martin Green(University of Nottingham), Lisa Mielniczuk(University of Ottawa), Robert Lemery(University of Ottawa)
The American Journal of Cardiology
May 7, 2006
10.1016/j.amjcard.2006.01.069
Cited by 95

Related Papers

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
|New England Journal of Medicine|2010|1.8k
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Amiodarone to Prevent Recurrence of Atrial Fibrillation
|New England Journal of Medicine|2000|1.2k
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
|EP Europace|2011|904
Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes
|New England Journal of Medicine|2000|777